New data suggest an approach that could improve the use of guideline-directed medical therapy among patients with heart ...

Weight Loss and Substance Use. In addition to being a key feature of many eating disorders, body image disturbance and a ...

Tens of thousands of Medicare beneficiaries who were on a Value Script drug plan will likely go without prescription drug ...

Medicare previously covered GLP-1s only if the beneficiary also had a condition such as diabetes, sleep apnea, high blood ...

The US Food and Drug Administration (FDA) and the medtech industry have agreed to commitment letter language for the Medical ...

A: A news article, and subsequently Democratic lawmakers, questioned whether Trump is receiving the Eli Lilly weight-loss drug, which is reportedly being given to one 79-year-old man. However, the ...

Q: Is President Trump the anonymous 79-year-old man getting a still-unapproved obesity drug via a Food and Drug ...

Amid an ongoing expansion of China’s volume-based procurement (VBP) scheme to lower drug costs, the Chinese government has ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...

FUJIFILM Biotechnologies (Fujifilm), a world-leading contract development and manufacturing organization (CDMO) for biologics ...

Discusses Accelerated FDA Approval of TRUTAKNA for IgA Nephropathy July 7, 2026 4:30 PM EDTCompany ParticipantsSean Grant ...

While some states ban insurers from using copay accumulator programs, oversight has stalled at the federal level.